NIOX Group Plc: Business Overview, Financials & Competitive Analysis
NIOX Group Plc scores 7/10 on the AskCyborg Cyborg Score (Strong). Focused respiratory diagnostics player with global reach, strong product-market fit, and recent innovation positioning for continued market share expansion. NIOX holds a market-leading position in the specialized FeNO diagnostic space with global distribution in 50+ countries and recent product innovation. However, the company faces typical medtech challenges including regulatory.
What is NIOX Group Plc's industry? NIOX Group Plc (niox.com) operates in Medical Devices - Respiratory Diagnostics. AskCyborg classifies NIOX Group Plc under Medical Devices - Respiratory Diagnostics in its company registry.
NIOX Group is a British medical device manufacturing company focused on products for treating respiratory diseases, producing NIOX (Nitric Oxide) FeNO devices to help diagnose and manage asthma. The NIOX VERO is a non...
Cyborg Score thesis
Focused respiratory diagnostics player with global reach, strong product-market fit, and recent innovation positioning for...
Read the full analyst-debate transcript →Get the Latest NIOX Group Plc Report
Up-to-date AI-powered research, analyst debate audio & saved-company playlists
Get Current Report FreeNIOX Group Plc Overview
Pro stress-test →NIOX Group is a British medical device manufacturing company focused on products for treating respiratory diseases, producing NIOX (Nitric Oxide) FeNO devices to help diagnose and manage asthma. The NIOX VERO is a non-invasive point-of-care system measuring Fractional Exhaled Nitric Oxide (FeNO) levels in patients.
Strategic Profile
Pro stress-test →NIOX products are available in over 50 countries with local teams and distributor networks providing customer support. The company derives a majority of its revenue from Asia Pacific with presence in the EU, US, UK, and other regions. The company launched the new NIOX PRO in December.
Competitive Landscape
Pro stress-test →NIOX operates in the specialized respiratory diagnostics market with limited direct competitors in FeNO measurement. Competitive threats include broader respiratory diagnostic platforms and potential new entrants, though NIOX maintains gold-standard positioning. Primary competition exists within asthma management tools and spirometry providers.
Industry Context
NIOX Group Plc operates in Medical Devices - Respiratory Diagnostics.
Key facts
Founded: 2006 · Headquarters: Oxford, UK · Employees: 51-200 · Market cap: £271.66m